Ovidac Injections (Generic Human Chorionic Gonadotropin Injections)

Ovidac (Generic Human Chorionic Gonadotropin Injection) Ovidac Injection (Generic Human Chorionic Gonadotropin Injection) is used in females to help conception occur. It is usually given in combination with other medicines such as menotropins and urofollitropin. Many women being treated with these medicines usually have already tried clomiphene alone (e.g., Serophene) and have not been able to conceive yet. Human Chorionic Gonadotropin is also used in in vitro fertilization (IVF) programs. Chorionic gonadotropin is a medicine whose medical effects are almost the same as those of Luteinizing Hormone (LH), which is produced by the pituitary gland.

Clearsky Pharmacy

www.clearskypharmacy.biz

Ovidac

Chorionic

In males, LH and Human Chorionic Gonadotropin (Ovidac injection) stimulate the testes to produce male hormones such as Testosterone. Testosterone causes the enlargement of the penis and testes and the growth of pubic and underarm hair. It also increases the production of sperm. Although Human Chorionic Gonadotropin has been prescribed to help some patients lose weight, it should never be used this way. When used improperly, Human Chorionic Gonadotropin (Ovidac) can cause serious problems.

Ovidac (Generic Human Chorionic Gonadotropin Injection)

Uses of Ovidac Injections

Prepubertal cryptorchidism not due to anatomical obstruction. In general, Human Chorionic Gonadotropin is thought to induce testicular descent in situations when descent would have occurred at puberty. HCG thus may help predict whether or not orchiopexy will be needed in the future. Although, in some cases, descent following HCG administration is permanent, in most cases, the response is temporary. Therapy is usually instituted between the ages four and nine. Selected cases of hypogonadotropic hypogonadism (hypogonadism secondary to a pituitary deficiency) in males. Ovidac Injection (Generic Human Chorionic Gonadotropin Injection) is also used for induction of ovulation and pregnancy in the anovulatory, infertile woman in whom the cause of anovulation is secondary and not due to primary ovarian failure, and who has been appropriately pretreated with human menotropins.

URL: https://www.clearskypharmacy.biz/ovidac-human-chorionic-gonadotropin-injection.html

Ovidac (Generic Human Chorionic Gonadotropin Injection)

Ovidac Injection Dosage

The dosage of Ovidac Injection (Generic Human Chorionic Gonadotropin Injection) is given below: In the Female: Sterility due to the absence of follicle-ripening or ovulation. 5,000 IU to 10,000 IU hCG to induce ovulation, following treatment with an FSH (Follicle Stimulating Hormone) or HMG (Human Menopausal Gonadotrophins) preparation. In combination with FSH (Follicle Stimulating Hormone) or HMG (Human Menopausal Gonadotrophin), promotion of controlled superovulation in medically assisted reproduction programmes. 5,000 IU to 10,000 IU hCG 30 to 40 hours after the last FSH or HMG injection. Ovidac injection should not be administered if the following criteria have not been met: at least 3 follicles greater than 17 mm in diameter are present with 17ß estradiol levels of at least 3500 pmol/L (920 picogram/ml). Oocyte collection is carried out 32 hours to 36 hours after the hCG injection has been administered.As luteal phase support, two to three injections of 1,000 to 3,000 IU hCG each may be given within nine days of ovulation or embryo transfer, for example on day 3, 6 and 9 after ovulation induction or embryo transfer.

URL: https://www.clearskypharmacy.biz/ovidac-human-chorionic-gonadotropin-injection.html

Clearsky Pharmacy ( www.clearskypharmacy.biz

Ovidac

Delayed

IU hCG

weekly

least

Sterility in selected cases of

Usually, 3,000 IU hCG per week in combination with an FSH or HMG preparation. This treatment must be continued for at least three months before any improvement in spermatogenesis can be expected. During this treatment

replacement therapy must be suspended. Once achieved, the improvement can sometimes be maintained by hCG alone.

Ovidac (Generic Human Chorionic Gonadotropin Injection)

Warnings

Ovidac injection should be used in conjunction with human menopausal gonadotropins only by physicians experienced with infertility problems who are familiar with the criteria for patient selection, contraindications, warnings, precautions, and adverse reactions. The principal serious adverse reactions are: (1) Ovarian hyperstimulation, a syndrome of sudden ovarian enlargement, ascites with or without pain and/or pleural effusion, (2) Rupture of ovarian cysts with resultant hemoperitoneum, (3) Multiple births and (4) Arterial thromboembolism. Anaphylaxis and other hypersensitivity reactions have been reported with urinary-derived hCG products. Since androgens may cause fluid retention, Human Chorionic Gonadotropin should be used with caution in patients with cardiac or renal disease, epilepsy, migraine, or asthma.

Chorionic

pregnancy.

has occurred.